Zobrazeno 1 - 10
of 133
pro vyhledávání: ''
Autor:
Melissa Bersanelli, Francesco Bonatti, Sebastiano Buti, Agnese Cosenza, Paola Bordi, Roberta Minari, Marcello Tiseo, Francesco Facchinetti, Gloria Cinquegrani, Andrea Ardizzoni, Elena Rapacchi, Leonarda Ferri, Alessandro Leonetti, Federico Quaini, Alessandra Dodi, Giulia Mazzaschi, Anna Squadrilli, Francesco Gelsomino
Publikováno v:
Tumori. 108(1)
Objective: To investigate the role of CTLA-4, PD-1 (programmed death-1), and PD-L1 (programmed death-ligand 1) single nucleotide polymorphisms (SNPs) in predicting clinical outcome of patients with advanced non-small cell lung cancer (NSCLC) treated
Autor:
Paolo Morgagni, Fabio Falcini, Flavia Foca, Giovanni Luca Frassineti, Massimo Framarini, Manlio Monti, Ilaria Massa, Alessandro Passardi
Publikováno v:
Tumori. 106(2)
Introduction: In a gastric cancer (GC) setting, phase II and III studies refer to an ideal patient population and only describe a specific category of patients. Older patients or those in poorer clinical condition are generally excluded from clinical
Autor:
Monica Di Tommaso, Antonietta Augurio, Consuelo Rosa, Domenico Genovesi, Luciana Caravatta, F. Perrotti, Isaia Al Zecca, Annamaria Vinciguerra, Marta Di Nicola, A. Allajbej, Marco Regoli
Publikováno v:
Tumori. 104(2)
Purpose: To report long-term effects on anorectal function and bowel disorders and late toxicity rate of preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Methods: Between 2000 and 2016, 201 patients treated with differe
Autor:
Virginia Ferraresi, Stefan S. Bielack, Anna Paioli, Nina L. Jebsen, Kirsten Sundby Hall, Peter Reichardt, Fatime Krasniqi, Bodil Bjerkehagen, Alessandra Longhi, Otte Brosjö, Thekla von Kalle, Emanuela Palmerini, Marco Gambarotti, Stefano Ferrari, Matthias Kevric, Rossella Bertulli, Per Ulf Tunn, Benjamin Sorg, Wolfgang E. Berdel, Piero Picci, Davide Maria Donati, Mikael Eriksson, Mathias Werner, Rudolf Schwarz, Odd R. Monge, Sylvie Lorenzen, Anne Katrin Kasparek, Marilena Cesari, Sigbjørn Smeland, Alessandro Comandone, Giovanni Grignani, Stefanie Hecker-Nolting, Gerlinde Egerer
Publikováno v:
Tumori. 104(1)
Introduction: The EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.) was the first prospective international study for patients 41-65 years old with high-grade bone sarcoma treated with an intensive chemotherapy regimen derived from protocols for yo
Autor:
Jun Itami, Koji Inaba, Hiroshi Igaki, Minako Sumi, Rei Umezawa, Yoshitaka Narita, Ken Harada, Masamichi Takahashi, Yasuji Miyakita, Makoto Ohno, Yoshinori Ito, Naoya Murakami
Publikováno v:
Tumori. 103(4)
Purpose To determine the clinical efficacy of surgery followed by local brain radiotherapy (LBRT) for patients with a single brain metastasis, by comparing the results with those of postoperative whole brain radiotherapy (WBRT). Methods We performed
Publikováno v:
Tumori. 104(3)
Objective: To explore the predictive value of diffusion-weighted imaging (DWI) in evaluating the short-term efficacy of concurrent chemoradiotherapy (CCRT) in the treatment of patients with non-small cell lung cancer (NSCLC). Methods: A total of 192
Autor:
Pierre-Yves Bondiau, Didier Peiffert, Raphaël Jumeau, Thierry Civit, Valérie Bernier-Chastagner, Julia Salleron, Cécile Parietti-Winkler
Publikováno v:
Tumori. 102(6)
Purpose Fractionated stereotactic radiotherapy (FSR) is a recognized treatment for vestibular schwannomas (VS). This study's aim is to present clinical outcomes and local control (LC) results for patients with VS treated with FSR using the Cyberknife
Autor:
Michele Del Vecchio, Lorenza Di Guardo, Barbara Valeri, Elena Tolomio, Filippo de Braud, Stefano Cavalieri, Aldo Bono, Anna Colombetti, Carolina Cimminiello, Giuseppe Di Tolla
Publikováno v:
Tumori. 102(5)
Purpose Combination therapy with dabrafenib and trametinib is safer and more effective than BRAF inhibitor-based monotherapy for metastatic melanoma. Methods We retrospectively analyzed BRAF-mutated metastatic melanoma patients treated at our institu
Autor:
Marco Gambarotti, Emanuela Palmerini, Cristina Ferrari, Alberto Righi, Luca Cevolani, Anna Paioli, Stefano Ferrari, Massimo Eraldo Abate, Daniel Vanel, Silvia Cammelli, Marilena Cesari, Alessandra Longhi, Piero Picci, Davide Maria Donati
Publikováno v:
Tumori. 102(5)
Purpose Patients with Ewing sarcoma who are 40 years old or older are usually excluded from clinical trials. For this reason, information on this subset of patients is limited. Methods Clinical characteristics and treatment-related variables of patie
Autor:
Özge Duran, Levent Akman, Aydın Özsaran, Arif Aras, Muzaffer Sanci, Ulas Solmaz, Mehmet Gökçü, Zeynep Özsaran, Senem Alanyali
Publikováno v:
Tumori. 2016(3)
Purpose Vulvar cancer is a relatively uncommon type of gynecologic cancer. The aim of this study is to analyze the treatment results and prognostic factors of vulvar cancer. Methods Forty-four vulvar cancer patients treated between 2000 and 2011 at t